BDX - Becton, Dickinson and Company

NYSE - NYSE Delayed Price. Currency in USD

Becton, Dickinson and Company

1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
201 847 6800

IndustryMedical Instruments & Supplies
Full Time Employees77,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Thomas E. Polen Jr.Pres, CEO & Chairman3.93M1.89M1973
Mr. Christopher J. DelOreficeExec. VP & CFO1.99MN/A1971
Ms. Shana Carol NealExec. VP & Chief People Officer1.44MN/A1967
Mr. David B. HickeyExec. VP & Pres of Life Sciences Segment1.41MN/A1963
Mr. Thomas J. SpoerelSr. VP, Controller & Chief Accounting OfficerN/AN/A1978
Ms. Elizabeth McCombsExec. VP & Chief Technology OfficerN/AN/A1976
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.Sr. VP, Chief Scientific Officer & Co-Chair of Scientific Advisory BoardN/AN/AN/A
Ms. Denise FlemingExec. VP of Technology & Global Services and Chief Information OfficerN/AN/AN/A
Ms. Francesca M. DeMartinoSr. VP & Head of Investor RelationsN/AN/AN/A
Ms. Michelle QuinnExec. VP & Gen. CounselN/AN/A1969
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Corporate Governance

Becton, Dickinson and Company’s ISS Governance QualityScore as of June 1, 2023 is 10. The pillar scores are Audit: 10; Board: 9; Shareholder Rights: 9; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.